1 Point Trademark Details
Word Mark | 1 Point |
---|---|
Status | Alive 774 — Opposition Pending |
Current Owner
Millennium Pharmaceuticals, Inc. of Cambridge, MA
View all trademarks for Millennium Pharmaceuticals, Inc.Serial Number | 86731782 |
---|---|
Status Date | Friday, July 15, 2016 |
Filing Date | Friday, July 15, 2016 |
Attorney | Mark I. Peroff |
Domestic Representative | Mark I. Peroff |
Correspondent
MARK I PEROFF
MANATT PHELPS & PHILLIPS LLP
7 TIMES SQ FL 21
NEW YORK, NY 10036-6524
MANATT PHELPS & PHILLIPS LLP
7 TIMES SQ FL 21
NEW YORK, NY 10036-6524
Case File Statements
Indication of Colors | The color(s) grey, orange, gold and white is/are claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of the number "1" in the color white appearing in the overlapping area of two triangles, one in the color grey, and one in orange and gold which is partially obstructed by the letter "P" in the word "POINT" appearing to the right of the triangles in orange stylized lettering. |
Goods & Services | Business administration of patient reimbursement program; Business administration of medication reimbursement programs |
Goods & Services | Providing insurance information and insurance reimbursement information; providing financial assistance for prescription costs |
Goods & Services | Providing medical and scientific research information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders and regarding pharmaceutical products relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders |
Goods & Services | Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; providing medical information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders |
Pseudo Mark | One Point |
Classifications
International Class Codes |
035
|
---|---|
U.S. Class Codes | 100, 101, 102 |
Status | 6 — Active |
Status Date | Wednesday, August 26, 2015 |
Primary Code | 035 |
International Class Codes |
036
|
---|---|
U.S. Class Codes | 100, 101, 102 |
Status | 6 — Active |
Status Date | Wednesday, August 26, 2015 |
Primary Code | 036 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Wednesday, August 26, 2015 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Wednesday, August 26, 2015 |
Primary Code | 044 |
Trademark Timeline
-
Aug 20 2015Trademark application filed with USPTO
-
Aug 24 2015New Application Entered In Tram
-
Aug 26 2015New Application Office Supplied Data Entered In Tram
-
Aug 27 2015Notice of Design Search Code and Pseudo Mark E-Mailed
-
Sep 21 2015Assigned To Examiner
-
Sep 23 2015Notification of Non-Final Action E-Mailed
-
Sep 23 2015Non-Final Action E-Mailed
-
Sep 23 2015Non-Final Action Written
-
Mar 23 2016Correspondence Received In Law Office
-
Mar 23 2016Teas Response To Office Action Received
-
Mar 24 2016Teas/email Correspondence Entered
-
Apr 05 2016Approved For Pub - Principal Register
-
Apr 27 2016Notification of Notice of Publication E-Mailed
-
May 17 2016Official Gazette Publication Confirmation E-Mailed
-
May 17 2016Published For Opposition
-
Jun 02 2016Extension of Time To Oppose Received
-
Jul 15 2016Opposition Instituted No. 999999